Drugs / Allergovac depot DPT/DF (50:50)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02881879 | Jul 2016 → Sep 2017 | allergic disease | Roxall Medicina España S.A | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allergovac depot DPT/DF (50:50) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02881879 ↗ |
| Modality | Vaccine | “vaccine of mixture of DPT and DF (50:50)” NCT02881879 ↗ |
| Route | Subcutaneous | “Subcutaneous immunotherapy” NCT02881879 ↗ |